Sirolimus in combination with tacrolimus or mycophenolate mofetil for minimizing acute rejection risk in renal transplant recipients—a single center experience

Saved in:
Bibliographic Details
Published inTransplantation proceedings Vol. 35; no. 3; pp. S89 - S94
Main Authors El-Sabrout, R, Delaney, V, Qadir, M, Butt, F, Hanson, P, Butt, K.M.H
Format Journal Article Conference Proceeding
LanguageEnglish
Published New York, NY Elsevier Inc 01.05.2003
Elsevier Science
Subjects
Acute Disease
Adult
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral agents
Area Under Curve
Biological and medical sciences
Child
Graft Rejection - prevention & control
Humans
Immunomodulators
Immunosuppressive Agents - pharmacokinetics
Immunosuppressive Agents - therapeutic use
Kidney Transplantation - immunology
Medical sciences
Mycophenolic Acid - analogs & derivatives
Mycophenolic Acid - therapeutic use
New York
Pharmacology. Drug treatments
Retrospective Studies
Sirolimus - pharmacokinetics
Sirolimus - therapeutic use
Tacrolimus - pharmacokinetics
Tacrolimus - therapeutic use
Mofetil
Graft(material)
Mycophenolic acid
Calcineurin inhibitor
Sirolimus
Risk
Transplantation
Homotransplantation
Kidney
Prevention
Surgery
Antiviral
Graft
Drug combination
Acute
Treatment efficiency
Lactone
Macrolide
Rejection
Antibiotic
Chemotherapy
Treatment
Urinary system
Tacrolimus
Risk factor
Immunosuppressive agent
Mycophenolate mofetil
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0041-1345
1873-2623
DOI:10.1016/S0041-1345(03)00220-3